Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide.
One of the factors affecting the pharmacokinetics (PK) of a drug during pregnancy is the activity of hepatic and placental metabolizing enzymes. Recently, we reported on the biotransformation of glyburide by human hepatic and placental microsomes to six metabolites that are structurally identical between the two tissues. Two of the metabolites, 4-trans-(M1) and 3-cis-hydroxycyclohexyl glyburide (M2b), were previously identified in plasma and urine of patients treated with glyburide and are pharmacologically active. The aim of this investigation was to identify the major human hepatic and placental CYP450 isozymes responsible for the formation of each metabolite of glyburide. This was achieved by the use of chemical inhibitors selective for individual CYP isozymes and antibodies raised against them. The identification was confirmed by the kinetic constants for the biotransformation of glyburide by cDNA-expressed enzymes. The data revealed that the major hepatic isozymes responsible for the formation of each metabolite are as follows: CYP3A4 (ethylene-hydroxylated glyburide (M5), 3-trans-(M3) and 2-trans-(M4) cyclohexyl glyburide); CYP2C9 (M1, M2a (4-cis-) and M2b); CYP2C8 (M1 and M2b); and CYP2C19 (M2a). Human placental microsomal CYP19/aromatase was the major isozyme responsible for the biotransformation of glyburide to predominantly M5. The formation of significant amounts of M5 by CYP19 in the placenta could render this metabolite more accessible to the fetal circulation. The multiplicity of enzymes biotransforming glyburide and the metabolites formed underscores the potential for its drug interactions in vivo.
Zharikova
Olga L
OL
Department of Obstetrics & Gynecology, University of Texas Medical Branch, Galveston, TX, 77555-0587, USA.
Fokina
Valentina M
VM
Nanovskaya
Tatiana N
TN
Hill
Ronald A
RA
Mattison
Donald R
DR
Hankins
Gary D V
GD
Ahmed
Mahmoud S
MS
D000906:Antibodies / Q000276:immunology; D003429:Cross Reactions; D003577:Cytochrome P-450 Enzyme System / Q000276:immunology / Q000378:metabolism; D005260:Female; D005905:Glyburide / Q000378:metabolism*; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D008099:Liver / Q000201:enzymology*; D008861:Microsomes / Q000201:enzymology; D008862:Microsomes, Liver / Q000201:enzymology; D010920:Placenta / Q000201:enzymology*; D011247:Pregnancy
D000906:Antibodies; D007527:Isoenzymes; D003577:Cytochrome P-450 Enzyme System; D005905:Glyburide
Clin Pharmacol Ther. 2002 Apr;71(4):253-62
11956508
Clin Pharmacokinet. 2004;43(8):487-514
15170365
Xenobiotica. 2000 Apr;30(4):327-43
10821163
Bioorg Med Chem. 2003 May 1;11(9):2099-113
12670661
J Pharmacol Exp Ther. 1994 Jul;270(1):414-23
8035341
J Pharmacol Exp Ther. 1996 Apr;277(1):321-32
8613937
Biochem Pharmacol. 2006 Aug 28;72(5):632-9
16828060
Diabetes Obes Metab. 2001 Dec;3(6):403-9
11903411
Xenobiotica. 2004 May;34(5):415-27
15370958
Biochem Pharmacol. 2006 Dec 15;72(12):1730-7
17011523
J Pharmacol Exp Ther. 2003 Sep;306(3):1099-105
12808001
Drug Metab Dispos. 2004 Aug;32(8):821-7
15258107
J Chromatogr. 1991 Mar 8;564(1):223-33
1907291
J Chromatogr A. 1998 Jan 23;794(1-2):15-25
9491553
Anal Biochem. 2000 Sep 10;284(2):427-30
10964434
J Clin Pharmacol New Drugs. 1973 Feb-Mar;13(2):68-75
4631138
Pharmacology. 2000 Sep;61(3):174-83
10971203
Br J Clin Pharmacol. 1997 Apr;43(4):373-81
9146849
Eur J Clin Pharmacol. 1975;8(1):63-9
823030
Pharmacogenet Genomics. 2007 Sep;17(9):731-42
17700362
Biochem Pharmacol. 1999 Mar 1;57(5):465-80
9952310
Clin Pharmacol Ther. 2002 Apr;71(4):286-96
11956512
Clin Pharmacol Ther. 2002 Sep;72(3):326-32
12235454
Biochem J. 1992 Jan 15;281 ( Pt 2):359-68
1736885
Drug Metab Dispos. 2003 Sep;31(9):1090-2
12920163
J Matern Fetal Neonatal Med. 2008 Mar;21(3):197-207
18297575
N Engl J Med. 2000 Oct 19;343(16):1134-8
11036118
Diabetes Care. 1991 Aug;14(8):724-7
1954808
Clin Pharmacokinet. 2004;43(15):1089-115
15568889
Biochem Pharmacol. 2007 Jun 15;73(12):2012-9
17462606
Yakugaku Zasshi. 2003 May;123(5):369-75
12772594
Clin Pharmacol Ther. 2009 Jun;85(6):607-14
19295505
Drug Metab Dispos. 1995 Jan;23(1):154-8
7720520
Clin Pharmacol Ther. 2005 Oct;78(4):370-7
16198656
J Pharmacol Exp Ther. 2001 Dec;299(3):849-57
11714868
Arzneimittelforschung. 1969 Aug;19(8):Suppl:1428-34
5394466
Biochem Pharmacol. 1996 Feb 23;51(4):403-11
8619884
Drug Metab Dispos. 1998 Aug;26(8):802-11
9698296
Am J Obstet Gynecol. 2005 Jul;193(1):118-24
16021069
Biochem Pharmacol. 2004 Mar 1;67(5):885-92
15104241
Biochem Pharmacol. 2004 Aug 1;68(3):583-91
15242824
Clin Pharmacol Ther. 2001 Jun;69(6):400-6
11406737